Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:05 PM
Ignite Modification Date:
2025-12-24 @ 1:05 PM
NCT ID:
NCT07247461
Eligibility Criteria:
Inclusion Criteria:
* Age \>18 years.
* Signed informed consent.
* CT scan compatible with LA (one or more cavitating lesions with liquid content).
* Clinical findings suggestive of ongoing infection.
* Lung abscess size ≥ 4 cm in diameter.
* Imaging indicates that the abscess contains fluid.
* The abscess involves the outer one-third of the lung.
Exclusion Criteria:
* Pregnancy. Prior to inclusion of fertile women, a negative pregnancy test must be available.
* Brest feeding.
* Predicted survival of less than 3 months.
* Known tuberculosis or non-tuberculous mycobacteriosis.
* Known chronic pulmonary aspergillosis.
* Patients with a primary suspicion of lung cancer
* Recent (\<3 months) contact with health facilities outside Scandinavia.
* Patients in whom anticoagulant treatment cannot be discontinued, or in whom the treatment pause does not allow drainage within 72 hours.
* Coagulopathy or other increased bleeding risk that cannot be corrected to allow drainage within 72 hours.
* Hemodynamic and/or respiratory unstable patient.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07247461
Study Brief:
Protocol Section:
NCT07247461